GAINESVILLE, Ga. — Not only is the U.S. poultry industry continuing its fight against these current outbreaks of highly pathogenic avian influenza, but the industry is also contending with occurrences of avian metapneumovirus. Approximately one month since the USDA announcement of approval of live avian metapneumovirus (aMPV) vaccine into the U.S., the agency announced that additional commercial modified live aMPV vaccines have gained import approval.
Avian metapneumovirus is a disease that affects the upper respiratory systems of turkeys, broilers, broiler/breeder, ducks, as well as wild bird species.
“The National Turkey Federation applauds USDA’s approval for. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
